1.
Carter BZ, Mak PY, Tao W, Warmoes M, Lorenzi PL, Mak D, Ruvolo V, Tan L, Cidado J, Drew L, Andreeff M. Targeting MCL-1 dysregulates cell metabolism and leukemia-stroma interactions and re-sensitizes acute myeloid leukemia to BCL-2 inhibition. haematol [Internet]. 2020Dec.23 [cited 2022Nov.27];107(1):58-6. Available from: https://haematologica.org/article/view/haematol.2020.260331